BACKGROUND: The mitotic rate was introduced as a major prognostic criterion for the staging of thin (≤1.0 mm) melanoma by the 2009 American Joint Committee on Cancer Staging and Classification (seventh edition). The detection of a single mitotic figure changes the tumor stage in thin melanoma. We sought to address the value of a dual staining to facilitate the determination of the mitotic rate and to assign the mitotic activity to melanocytes. METHODS: The mitotic rate of melanoma cells was determined by dual phosphohistone-H3 (PHH3)/Melan-A immunohistochemistry. Results were compared with PHH3 staining alone and conventional hematoxylin and eosin (H&E)-stained slides of 15 melanomas with a tumor thickness <1.0 mm. RESULTS: PHH3 staining clearly labeled cells in the mitotic cell cycle. The mitotic rate in the PHH3/Melan-A dual stain was equal to that derived by H&E staining. Time required for counting mitotic figures was significantly reduced. CONCLUSIONS: The evaluation of mitotic rate with an immunohistochemical dual stain is faster (mean 63.0%) and more reliable than evaluation by routine H&E staining alone. Dual staining immunohistochemistry may be a useful additional tool to standardize the determination of mitotic rate and may be helpful in evaluation of challenging cases.
BACKGROUND: The mitotic rate was introduced as a major prognostic criterion for the staging of thin (≤1.0 mm) melanoma by the 2009 American Joint Committee on Cancer Staging and Classification (seventh edition). The detection of a single mitotic figure changes the tumor stage in thin melanoma. We sought to address the value of a dual staining to facilitate the determination of the mitotic rate and to assign the mitotic activity to melanocytes. METHODS: The mitotic rate of melanoma cells was determined by dual phosphohistone-H3 (PHH3)/Melan-A immunohistochemistry. Results were compared with PHH3 staining alone and conventional hematoxylin and eosin (H&E)-stained slides of 15 melanomas with a tumor thickness <1.0 mm. RESULTS:PHH3 staining clearly labeled cells in the mitotic cell cycle. The mitotic rate in the PHH3/Melan-A dual stain was equal to that derived by H&E staining. Time required for counting mitotic figures was significantly reduced. CONCLUSIONS: The evaluation of mitotic rate with an immunohistochemical dual stain is faster (mean 63.0%) and more reliable than evaluation by routine H&E staining alone. Dual staining immunohistochemistry may be a useful additional tool to standardize the determination of mitotic rate and may be helpful in evaluation of challenging cases.
Authors: Stevan R Knezevich; Raymond L Barnhill; David E Elder; Michael W Piepkorn; Lisa M Reisch; Gaia Pocobelli; Patricia A Carney; Joann G Elmore Journal: J Am Acad Dermatol Date: 2014-09-16 Impact factor: 11.527
Authors: Christopher S Hale; Meng Qian; Michelle W Ma; Patrick Scanlon; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Yongzhao Shao; David Polsky; Iman Osman; Farbod Darvishian Journal: Am J Surg Pathol Date: 2013-06 Impact factor: 6.394
Authors: Jane H Zhou; Kevin B Kim; Jeffrey N Myers; Patricia S Fox; Jing Ning; Roland L Bassett; Hassan Hasanein; Victor G Prieto Journal: Am J Dermatopathol Date: 2014-01 Impact factor: 1.533
Authors: Michael T Tetzlaff; Carlos A Torres-Cabala; Penvadee Pattanaprichakul; Ronald P Rapini; Victor G Prieto; Jonathan L Curry Journal: Clin Cosmet Investig Dermatol Date: 2015-01-30
Authors: Bih-Rong Wei; Charles H Halsey; Shelley B Hoover; Munish Puri; Howard H Yang; Brandon D Gallas; Maxwell P Lee; Weijie Chen; Amy C Durham; Jennifer E Dwyer; Melissa D Sánchez; Ryan P Traslavina; Chad Frank; Charles Bradley; Lawrence D McGill; D Glen Esplin; Paula A Schaffer; Sarah D Cramer; L Tiffany Lyle; Jessica Beck; Elizabeth Buza; Qi Gong; Stephen M Hewitt; R Mark Simpson Journal: Acad Pathol Date: 2019-07-11
Authors: Danielle R Martinez; Hunter W Richards; Qiushi Lin; Carlos A Torres-Cabala; Victor G Prieto; Jonathan L Curry; Estela E Medrano Journal: J Skin Cancer Date: 2012-11-25